Table 1.
Characteristic | CMV group (56) | Non-CMV group (57) | P value |
---|---|---|---|
Sex of patient | 0.644 | ||
Male | 31 (55.36) | 34 (59.65) | |
Female | 25 (44.64) | 23 (40.35) | |
Age of patients | 0.024 | ||
Mean ± SD | 30±268 | 23±274 | |
Min - Max | 2-59 | 1-62 | |
Median (IQR) | 31 | 27 | |
Underlying disease | |||
Acute myeloid leukemia | 40 (71.43) | 42 (73.68) | 0.447 |
Acute lymphoid leukemia | 8 (14.28) | 6 (10.52) | |
Myelodysplastic syndromes | 2 (3.57) | 4 (7.02) | |
Chronic myeloid leukemia | 1 (1.79) | 3 (5.26) | |
Lymphoma | 4 (7.14) | 1 (1.75) | |
Plasma cellular leukemia | 1 (1.79) | 0 (0) | |
Acute mixed leukemia | 0 (0) | 1 (1.75) | |
Disease status | 0.459 | ||
CR | 35 (62.50) | 30 (55.56) | |
NR | 21 (37.50) | 24 (44.44) | |
HCT-CI | 0.932 | ||
Mean ± SD | 0.84±0.621 | 0.82±1.058 | |
Min - Max | 0-3 | 0-5 | |
Median (IQR) | 1.00 | 1.00 | |
Donor type | 0.689 | ||
HLA mismatched, related | 51 (91.07) | 54 (94.74) | |
HLA mismatched, unrelated | 4 (7.14) | 2 (3.51) | |
Unrelated cord blood | 1 (1.79) | 1 (1.75) | |
Graft source | < 0.001 | ||
Peripheral blood | 39 (69.64) | 55 (96.49) | |
Bone marrow + Peripheral blood | 16 (28.57) | 1 (1.75) | |
Umbilical cord blood | 1 (1.79) | 1 (1.75) | |
Conditioning | 0.792 | ||
Reduced intensity | 9 (16.07) | 8 (14.03) | |
Myeloablative | 47 (83.93) | 49 (85.96) | |
ABO disparity | 0.487 | ||
None | 30 (55.56) | 30 (52.63) | |
Minor | 5 (9.26) | 11 (19.30) | |
Major | 14 (25.93) | 12 (21.05) | |
Bidirectional | 5 (9.26) | 4 (7.02) | |
Sex of donor | 56 | 0.825 | |
Male | 39 (73.58) | 43 (76.79) | |
Female | 14 (26.42) | 13 (23.21) | |
Age of donor | 0.431 | ||
Mean ± SD | 32.92±162.38 | 34.98±199.94 | |
Min - Max | 9-63 | 7-59 | |
Median (IQR) | 33.00 | 38.50 | |
MNC, ×108/kg | 0.769 | ||
Mean ± SD | 9.80±9.40 | 10.00±15.67 | |
Min - Max | 4.84-19.32 | 1.91-23.5 | |
Median (IQR) | 9.54 | 8.98 | |
CD34+ cell, ×106/kg | < 0.001 | ||
Mean ± SD | 5.15±5.58 | 6.88±7.35 | |
Min - Max | 1.05-9.12 | 1.2-16.92 | |
Median (IQR) | 5.00 | 6.70 |